Show/hide main menu

Gerd Wagner

Dr Gerd Wagner

gw1Reader in Medicinal Chemistry
Telephone number: +44 (0)207 848 4747
Email address: gerd.wagner@kcl.ac.uk

https://kclpure.kcl.ac.uk/portal/gerd.wagner.html

 

 

 

 

 

 

King's Postal Address:
Institute of Pharmaceutical Science
King's College London
5th Floor, Franklin-Wilkins Building
150 Stamford Street
London SE1 9NH

 

About Gerd

Gerd Wagner is currently a Reader in Medicinal Chemistry at King’s College London. Originally from beautiful South Germany, Gerd holds a degree in Pharmacy from the University of Freiburg and a PhD in Medicinal Chemistry (advisor: Professor Stefan Laufer) from the University of Tuebingen – two of Germany’s oldest and most prestigious academic institutions. In 2002, he joined the group of Professor Barry Potter at the University of Bath (UK) for postdoctoral studies on the role of cADPR (cyclic adenosine diphosphate ribose) and related dinucleotides in calcium signalling. He stayed in the UK to start his independent academic career, taking up a lectureship in Medicinal Chemistry at the University of East Anglia in 2004. In 2010, he moved to King’s College London, first as a Senior Lecturer, and since 2012 as a Reader. At King’s, he is based jointly in the Institute of Pharmaceutical Science and the new Department of Chemistry. In Chemistry, he is the programme director for the new undergraduate programme “Chemistry with Biomedicine”, which has taken its first students in September 2012. With Helen Hailes (UCL) and Andrew Stachulski (Oxford), he has organised the first Joint Meeting of the RSC Carbohydrate and Bioorganic Interest Groups, held at King’s College in April 2011.

 

Gerd’s main research interests are in medicinal chemistry and chemical biology, and his work has recently been highlighted in a “Young Researcher” profile in MedChemWatch, the official newsletter of the European Federation for Medicinal Chemistry (EFMC). A primary target are glycosyltransferases, Nature’s glycosylation agents. These enzymes are promising molecular targets in a range of therapeutic areas, from infection to inflammation and cancer, and research in the Wagner group has recently led to the discovery of a novel type of allosteric inhibitor for glycosyltransferases (Nat Chem Biol 2010, 6, 321-323). Details about this and other current projects in the group can be found on the “Research” page, and also on the pages of individual group members (see links at the bottom of this page).

The Wagner group is very international and interdisciplinary: members of the group hail from Austria, Finland, Germany, India, Italy as well as the UK, and have a background in synthetic-organic as well as medicinal and analytical chemistry, biochemistry and pharmacy.

We are always looking to recruit talented and motivated scientists. If you are interested in joining the Wagner group, then please feel free to contact Gerd directly.

Sitemap Site help Terms and conditions Privacy policy Accessibility Modern slavery statement Contact us

© 2017 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454